Annovis Bio, Inc. (ANVS) NYSE

3.12

-0.33(-9.57%)

Updated at January 13 04:00PM

Currency In USD

Valuation

Market Cap61.28M
Enterprise Value50.72M
P/E Ratio-2.47
PEG Ratio-0.08
Price/Sales Ratio0
Price/Book Ratio4.67
Enterprise/Revenue0
Enterprise/EBITDA-1.74

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.45
Return On Equity-1.53

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-26.69M
Net Income-24.59M
Diluted EPS-2,009.77

Balance Sheet

Total Cash15.29M
Total Cash/Share0.78
Total Debt0
Total Debt/Equity0
Current Ratio4.6
Book Value Per Share0.67

Price History

52-Week Change-33.19
52-Week High5.5
52-Week Low1.11
Moving Average 50 Days3.51
Moving Average 200 Days2.53

Statistics

Average Volume1.69M
Shares Outstanding19.67M
% Held by Institutions10.39

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A